Cargando…

Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration

BACKGROUND: Vitamin C suppresses leukaemogenesis by modulating Tet methylcytosine dioxygenase (TET) activity. However, its beneficial effect in the treatment of patients with acute myeloid leukaemia (AML) remains controversial. In this study, we aimed to identify a potential predictive biomarker for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jun, Hong, Junshik, Han, Heejoo, Park, Jihyun, Kim, Dongchan, Park, Hyejoo, Ko, Myunggon, Koh, Youngil, Shin, Dong-Yeop, Yoon, Sung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217885/ https://www.ncbi.nlm.nih.gov/pubmed/32203209 http://dx.doi.org/10.1038/s41416-020-0788-8

Ejemplares similares

Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment
por: Lee, Chansub, et al.
Publicado: (2022)

Epigenetic priming improves salvage chemotherapy in diffuse large B-cell lymphoma via endogenous retrovirus-induced cGAS-STING activation
por: Liu, Jun, et al.
Publicado: (2023)

Functions of TET Proteins in Hematopoietic Transformation
por: Han, Jae-A, et al.
Publicado: (2015)

TET family dioxygenases and DNA demethylation in stem cells and cancers
por: An, Jungeun, et al.
Publicado: (2017)

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
por: Ko, Myunggon, et al.
Publicado: (2010)

Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins
por: Kim, Hyejin, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
por: Park, Songyi, et al.
Publicado: (2021)

Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
por: Park, Woochan, et al.
Publicado: (2023)

P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS
por: Min Byun, Ja, et al.
Publicado: (2023)

Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
por: Han, Heejoo, et al.
Publicado: (2021)

DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells
por: Zhang, Xiaotian, et al.
Publicado: (2016)

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
por: Park, Hyunkyung, et al.
Publicado: (2022)

Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype
por: Kim, Sang-A, et al.
Publicado: (2018)

Loss of adipose TET proteins enhances β-adrenergic responses and protects against obesity by epigenetic regulation of β3-AR expression
por: Byun, Seongjun, et al.
Publicado: (2022)

Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
por: Seo, Jeongmin, et al.
Publicado: (2021)

Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019)

Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms
por: Kim, Jinyong, et al.
Publicado: (2021)

Acute loss of TET function results in aggressive myeloid cancer in mice
por: An, Jungeun, et al.
Publicado: (2015)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

PB1859: DNMT3A MUTATION PATTERNS AND CLINICAL FEATURES IN KOREAN ACUTE MYELOID LEUKEMIA PATIENTS
por: Lee, Eunyoung, et al.
Publicado: (2023)

Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies
por: Hong, Junshik, et al.
Publicado: (2020)

Restored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cells
por: FAN, MIN, et al.
Publicado: (2015)

Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
por: Lee, Ahreum, et al.
Publicado: (2020)

Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma
por: Huang, Rong, et al.
Publicado: (2020)

Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients
por: Ahn, Hyun Jin, et al.
Publicado: (2022)

Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
por: Kim, Dong Hyun, et al.
Publicado: (2022)

Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
por: Park, Hyunkyung, et al.
Publicado: (2019)

Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors
por: Barazeghi, Elham, et al.
Publicado: (2018)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency
por: Costa, Yael, et al.
Publicado: (2013)

Inducible disruption of Tet genes results in myeloid malignancy, readthrough transcription, and a heterochromatin-to-euchromatin switch
por: Yuita, Hiroshi, et al.
Publicado: (2023)

Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high‐risk multiple myeloma in Asian patients
por: Byun, Ja Min, et al.
Publicado: (2018)

High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy
por: Kim, Eun Young, et al.
Publicado: (2020)

Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission?
por: Byun, Ja Min, et al.
Publicado: (2021)

Loss of TET2 and TET3 in regulatory T cells unleashes effector function
por: Yue, Xiaojing, et al.
Publicado: (2019)

TET2 and TET3 loss disrupts small intestine differentiation and homeostasis
por: Ansari, Ihab, et al.
Publicado: (2023)

P726: TET2 ALLELIC BURDEN IMPRINTS A CONTEXT-DEPENDENT PROGNOSTIC SIGNIFICANCE OF ASXL1 MUTATION IN CHRONIC MYELOMONOCYTIC LEUKAEMIA
por: Wang, Yu-Hung, et al.
Publicado: (2023)

RTK-RAS pathway mutation is enriched in myeloid sarcoma
por: Choi, Mihong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vnhn53a8ggjadsbm62gjnacgeg